Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Trial to Assess Safety and Activity of Standardized Withaferin A as GvHD Prophylaxis in Patients Undergoing Matched Related Donor Hematopoietic Stem Cell Transplant

NCT07724873 is registered in ClinicalTrials.gov with Tata Memorial Centre as lead sponsor.

NCT NCT07724873
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07724873 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Trial to Assess Safety and Activity of Standardized Withaferin A as GvHD Prophylaxis in Patients Undergoing Matched Related Donor Hematopoietic Stem Cell Transplant
Lead sponsor
Tata Memorial Centre
Phase
Phase 1/2
Overall status
Recruiting
Start date
January 28, 2025
Completion date
December 3, 2029
Enrollment
54 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

gvhd - graft-versus-host disease, hematological malignancy, hematopoietic stem cell transplant (hsct)